查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402884

脑癌诊断市场 - 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

Brain Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

脑癌诊断市场 - 报告范围

TMR 关于全球脑癌诊断市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球脑癌诊断的收入2017-2031年期间的市场，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球脑癌诊断市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解脑癌诊断市场。

市场概况
2023年市场价值 15亿美元
2031 年市场价值 25亿美元
CAGR 5.9%

该报告深入研究了全球脑癌诊断市场的竞争格局。全球脑癌诊断市场的主要参与者已经确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球脑癌诊断市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2023-2031 年全球市场分析与预测

第 5 章：关键见解

  • 脑肿瘤流行病学
  • 脑肿瘤诊断和治疗影像的当前趋势
  • 癌症诊断技术的进步
  • COVID-19 影响分析

第 6 章：全球市场分析与预测：透过诊断技术

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依诊断技术，2023-2031
    • 影像技术
      • 磁振造影 (MRI)
      • 电脑断层扫描 (CT) 扫描
      • PET 扫描或 PET-CT 扫描
      • (SPECT) 扫描
    • 组织取样/活检
    • 分子诊断
    • 其他的
  • 市场吸引力分析：透过诊断技术

第 7 章：全球市场分析与预测：按脑癌类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按脑癌类型，2023-2031
    • 神经胶质瘤
    • 脑膜瘤
    • 脑下垂体肿瘤
    • 其他的
  • 市场吸引力分析：按脑癌类型

第 8 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2023-2031
    • 医院
    • 诊断实验室
    • 癌症医院/中心
  • 市场吸引力分析：按最终用户

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 公司市占率分析（2021 年）
  • 公司简介
    • GE Healthcare
    • Siemens Healthineers
    • Philips Healthcare
    • Thermo Fisher Scientific
    • Roche Diagnostics
    • Abbott Laboratories
    • Illumina, Inc.
    • Hologic, Inc.
    • Agilent Technologies
    • Bio-Rad Laboratories
Product Code: TMRGL85859

Brain Cancer Diagnostics Market - Scope of Report

TMR's report on the global brain cancer diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global brain cancer diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global brain cancer diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the brain cancer diagnostics market.

Market Snapshot
Market Value in 2023US$ 1.5 Bn
Market Value in 2031US$ 2.5 Bn
CAGR5.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global brain cancer diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global brain cancer diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global brain cancer diagnostics market.

The report delves into the competitive landscape of the global brain cancer diagnostics market. Key players operating in the global brain cancer diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global brain cancer diagnostics market profiled in this report.

Key Questions Answered in Global brain cancer diagnostics Market Report:

  • What is the sales/revenue generated by brain cancer diagnostics across all regions during the forecast period?
  • What are the opportunities in the global brain cancer diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Brain Cancer Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global brain cancer diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global brain cancer diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global brain cancer diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Brain Cancer Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Brain Cancer Diagnostics Market Analysis and Forecasts, 2023-2031

5. Key Insights

  • 5.1. Brain Tumor Epidemiology
  • 5.2. Current Trends in Diagnostic and Therapeutic Imaging of Brain Tumors
  • 5.3. Technological advancements in cancer diagnostics
  • 5.4. COVID-19 Impact Analysis

6. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by Diagnostic Technique

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Diagnostic Technique, 2023-2031
    • 6.3.1. Imaging Techniques
      • 6.3.1.1. Magnetic Resonance Imaging (MRI)
      • 6.3.1.2. Computed Tomography (CT) Scan
      • 6.3.1.3. PET Scan or PET-CT Scan
      • 6.3.1.4. (SPECT) Scan
    • 6.3.2. Tissue Sampling/Biopsy
    • 6.3.3. Molecular Diagnostics
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Diagnostic Technique

7. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by Brain Cancer Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
    • 7.3.1. Gliomas
    • 7.3.2. Meningiomas
    • 7.3.3. Pituitary Tumors
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Brain Cancer Type

8. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2023-2031
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Laboratories
    • 8.3.3. Cancer Hospitals/Centers
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Brain Cancer Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
    • 10.2.1. Imaging Techniques
      • 10.2.1.1. Magnetic Resonance Imaging (MRI)
      • 10.2.1.2. Computed Tomography (CT) Scan
      • 10.2.1.3. PET Scan or PET-CT Scan
      • 10.2.1.4. (SPECT) Scan
    • 10.2.2. Tissue Sampling/Biopsy
    • 10.2.3. Molecular Diagnostics
    • 10.2.4. Others
  • 10.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
    • 10.3.1. Gliomas
    • 10.3.2. Meningiomas
    • 10.3.3. Pituitary Tumors
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by End-user, 2023-2031
    • 10.4.1. Hospitals
    • 10.4.2. Diagnostic Laboratories
    • 10.4.3. Cancer Hospitals/Centers
  • 10.5. Market Value Forecast, by Country, 2023-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Diagnostic Technique
    • 10.6.2. By Brain Cancer Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Brain Cancer Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
    • 11.2.1. Imaging Techniques
      • 11.2.1.1. Magnetic Resonance Imaging (MRI)
      • 11.2.1.2. Computed Tomography (CT) Scan
      • 11.2.1.3. PET Scan or PET-CT Scan
      • 11.2.1.4. (SPECT) Scan
    • 11.2.2. Tissue Sampling/Biopsy
    • 11.2.3. Molecular Diagnostics
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
    • 11.3.1. Gliomas
    • 11.3.2. Meningiomas
    • 11.3.3. Pituitary Tumors
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by End-user, 2023-2031
    • 11.4.1. Hospitals
    • 11.4.2. Diagnostic Laboratories
    • 11.4.3. Cancer Hospitals/Centers
  • 11.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Diagnostic Technique
    • 11.6.2. By Brain Cancer Type
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Brain Cancer Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
    • 12.2.1. Imaging Techniques
      • 12.2.1.1. Magnetic Resonance Imaging (MRI)
      • 12.2.1.2. Computed Tomography (CT) Scan
      • 12.2.1.3. PET Scan or PET-CT Scan
      • 12.2.1.4. (SPECT) Scan
    • 12.2.2. Tissue Sampling/Biopsy
    • 12.2.3. Molecular Diagnostics
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
    • 12.3.1. Gliomas
    • 12.3.2. Meningiomas
    • 12.3.3. Pituitary Tumors
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by End-user, 2023-2031
    • 12.4.1. Hospitals
    • 12.4.2. Diagnostic Laboratories
    • 12.4.3. Cancer Hospitals/Centers
  • 12.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Diagnostic Technique
    • 12.6.2. By Brain Cancer Type
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Brain Cancer Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
    • 13.2.1. Imaging Techniques
      • 13.2.1.1. Magnetic Resonance Imaging (MRI)
      • 13.2.1.2. Computed Tomography (CT) Scan
      • 13.2.1.3. PET Scan or PET-CT Scan
      • 13.2.1.4. (SPECT) Scan
    • 13.2.2. Tissue Sampling/Biopsy
    • 13.2.3. Molecular Diagnostics
    • 13.2.4. Others
  • 13.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
    • 13.3.1. Gliomas
    • 13.3.2. Meningiomas
    • 13.3.3. Pituitary Tumors
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by End-user, 2023-2031
    • 13.4.1. Hospitals
    • 13.4.2. Diagnostic Laboratories
    • 13.4.3. Cancer Hospitals/Centers
  • 13.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Diagnostic Technique
    • 13.6.2. By Brain Cancer Type
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Brain Cancer Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
    • 14.2.1. Imaging Techniques
      • 14.2.1.1. Magnetic Resonance Imaging (MRI)
      • 14.2.1.2. Computed Tomography (CT) Scan
      • 14.2.1.3. PET Scan or PET-CT Scan
      • 14.2.1.4. (SPECT) Scan
    • 14.2.2. Tissue Sampling/Biopsy
    • 14.2.3. Molecular Diagnostics
    • 14.2.4. Others
  • 14.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
    • 14.3.1. Gliomas
    • 14.3.2. Meningiomas
    • 14.3.3. Pituitary Tumors
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by End-user, 2023-2031
    • 14.4.1. Hospitals
    • 14.4.2. Diagnostic Laboratories
    • 14.4.3. Cancer Hospitals/Centers
  • 14.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Diagnostic Technique
    • 14.6.2. By Brain Cancer Type
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2021)
  • 15.3. Company Profiles
    • 15.3.1. GE Healthcare
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Strategic Overview
      • 15.3.1.5. SWOT Analysis
    • 15.3.2. Siemens Healthineers
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Strategic Overview
      • 15.3.2.5. SWOT Analysis
    • 15.3.3. Philips Healthcare
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Strategic Overview
      • 15.3.3.5. SWOT Analysis
    • 15.3.4. Thermo Fisher Scientific
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Strategic Overview
      • 15.3.4.5. SWOT Analysis
    • 15.3.5. Roche Diagnostics
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Strategic Overview
      • 15.3.5.5. SWOT Analysis
    • 15.3.6. Abbott Laboratories
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Strategic Overview
      • 15.3.6.5. SWOT Analysis
    • 15.3.7. Illumina, Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Strategic Overview
      • 15.3.7.5. SWOT Analysis
    • 15.3.8. Hologic, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Strategic Overview
      • 15.3.8.5. SWOT Analysis
    • 15.3.9. Agilent Technologies
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Strategic Overview
      • 15.3.9.5. SWOT Analysis
    • 15.3.10. Bio-Rad Laboratories
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Strategic Overview
      • 15.3.10.5. SWOT Analysis

List of Tables

  • Table 01: Global Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Technique, 2023-2031
  • Table 02: Global Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Brain Cancer Type, 2023-2031
  • Table 03: Global Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 04: Global Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 05: North America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Technique, 2023-2031
  • Table 06: North America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Brain Cancer Type, 2023-2031
  • Table 07: North America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 08: North America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 09: Europe Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Technique, 2023-2031
  • Table 10: Europe Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Brain Cancer Type, 2023-2031
  • Table 11: Europe Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 12: Europe Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 13: Asia Pacific Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Technique, 2023-2031
  • Table 14: Asia Pacific Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Brain Cancer Type, 2023-2031
  • Table 15: Asia Pacific Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 16: Asia Pacific Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 17: Latin America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Technique, 2023-2031
  • Table 18: Latin America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Brain Cancer Type, 2023-2031
  • Table 19: Latin America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 20: Latin America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 21: Middle East & Africa Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Technique, 2023-2031
  • Table 22: Middle East & Africa Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Brain Cancer Type, 2023-2031
  • Table 23: Middle East & Africa Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 24: Middle East & Africa Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

List of Figures

  • Figure 01: Global Brain Cancer Diagnostics Market Value (US$ Mn) Forecast 2023-2031
  • Figure 02: Global Brain Cancer Diagnostics Market Value Share, by Diagnostic Technique 2023
  • Figure 03: Global Brain Cancer Diagnostics Market Value Share, by Brain Cancer Type 2023
  • Figure 04: Global Brain Cancer Diagnostics Market Value Share, by End-user 2023
  • Figure 05: Global Brain Cancer Diagnostics Market Value Share Analysis, by Diagnostic Technique 2023 and 2031
  • Figure 06: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Imaging Techniques 2023-2031
  • Figure 07: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Tissue Sampling/Biopsy 2023-2031
  • Figure 08: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Molecular Diagnostics 2023-2031
  • Figure 09: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Others 2023-2031
  • Figure 10: Global Brain Cancer Diagnostics Market Attractiveness Analysis, by Brain Cancer Type 2023-2031
  • Figure 11: Global Brain Cancer Diagnostics Market Value Share Analysis, by Brain Cancer Type 2023 and 2031
  • Figure 12: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Gliomas 2023-2031
  • Figure 13: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Meningiomas 2023-2031
  • Figure 14: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Pituitary Tumors 2023-2031
  • Figure 15: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Others 2023-2031
  • Figure 16: Global Brain Cancer Diagnostics Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 17: Global Brain Cancer Diagnostics Market Value Share Analysis, by End-user 2023 and 2031
  • Figure 18: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Hospitals 2023-2031
  • Figure 19: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Diagnostic Laboratories 2023-2031
  • Figure 20: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Cancer Hospitals/Centers 2017-2032
  • Figure 21: Global Brain Cancer Diagnostics Market Value Share Analysis, by Region 2023 and 2031
  • Figure 22: Global Brain Cancer Diagnostics Market Attractiveness Analysis, by Region 2023-2031
  • Figure 23: North America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast 2023-2031
  • Figure 24: North America Brain Cancer Diagnostics Market Value Share Analysis, by Country 2023 and 2031
  • Figure 25: North America Brain Cancer Diagnostics Market Attractiveness Analysis, by Country 2023-2031
  • Figure 26: North America Brain Cancer Diagnostics Market Value Share Analysis, by Diagnostic Technique 2023 and 2031
  • Figure 27: North America Brain Cancer Diagnostics Market Attractiveness Analysis, by Diagnostic Technique 2023-2031
  • Figure 28: North America Brain Cancer Diagnostics Market Value Share Analysis, by Brain Cancer Type 2023 and 2031
  • Figure 29: North America Brain Cancer Diagnostics Market Attractiveness Analysis, by Brain Cancer Type 2023-2031
  • Figure 30: North America Brain Cancer Diagnostics Market Value Share Analysis, by End-user 2023 and 2031
  • Figure 31: North America Brain Cancer Diagnostics Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 32: Europe Brain Cancer Diagnostics Market Value (US$ Mn) Forecast 2023-2031
  • Figure 33: Europe Brain Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
  • Figure 34: Europe Brain Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 35: Europe Brain Cancer Diagnostics Market Value Share Analysis, by Diagnostic Technique 2023 and 2031
  • Figure 36: Europe Brain Cancer Diagnostics Market Attractiveness Analysis, by Diagnostic Technique 2023-2031
  • Figure 37: Europe Brain Cancer Diagnostics Market Value Share Analysis, by Brain Cancer Type 2023 and 2031
  • Figure 38: Europe Brain Cancer Diagnostics Market Attractiveness Analysis, by Brain Cancer Type 2023-2031
  • Figure 39: Europe Brain Cancer Diagnostics Market Value Share Analysis, by End-user 2023 and 2031
  • Figure 40: Europe Brain Cancer Diagnostics Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 41: Asia Pacific Brain Cancer Diagnostics Market Value (US$ Mn) Forecast 2023-2031
  • Figure 42: Asia Pacific Brain Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
  • Figure 43: Asia Pacific Brain Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 44: Asia Pacific Brain Cancer Diagnostics Market Value Share Analysis, by Diagnostic Technique 2023 and 2031
  • Figure 45: Asia Pacific Brain Cancer Diagnostics Market Attractiveness Analysis, by Diagnostic Technique 2023-2031
  • Figure 46: Asia Pacific Brain Cancer Diagnostics Market Value Share Analysis, by Brain Cancer Type 2023 and 2031
  • Figure 47: Asia Pacific Brain Cancer Diagnostics Market Attractiveness Analysis, by Brain Cancer Type 2023-2031
  • Figure 48: Asia Pacific Brain Cancer Diagnostics Market Value Share Analysis, by End-user 2023 and 2031
  • Figure 49: Asia Pacific Brain Cancer Diagnostics Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 50: Latin America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast 2023-2031
  • Figure 51: Latin America Brain Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
  • Figure 52: Latin America Brain Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 53: Latin America Brain Cancer Diagnostics Market Value Share Analysis, by Diagnostic Technique 2023 and 2031
  • Figure 54: Latin America Brain Cancer Diagnostics Market Attractiveness Analysis, by Diagnostic Technique 2023-2031
  • Figure 55: Latin America Brain Cancer Diagnostics Market Value Share Analysis, by Brain Cancer Type 2023 and 2031
  • Figure 56: Latin America Brain Cancer Diagnostics Market Attractiveness Analysis, by Brain Cancer Type 2023-2031
  • Figure 57: Latin America Brain Cancer Diagnostics Market Value Share Analysis, by End-user 2023 and 2031
  • Figure 58: Latin America Brain Cancer Diagnostics Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 59: Middle East & Africa Brain Cancer Diagnostics Market Value (US$ Mn) 2023-2031
  • Figure 60: Middle East & Africa Brain Cancer Diagnostics Market Value Share Analysis, by Country 2023 and 2031
  • Figure 61: Middle East & Africa Brain Cancer Diagnostics Market Attractiveness , by Country 2023-2031
  • Figure 62: Middle East & Africa Brain Cancer Diagnostics Market Value Share Analysis, by Diagnostic Technique 2023 and 2031
  • Figure 63: Middle East & Africa Brain Cancer Diagnostics Market Attractiveness , by Diagnostic Technique 2023-2031
  • Figure 64: Middle East & Africa Brain Cancer Diagnostics Market Value Share Analysis, by Brain Cancer Type 2023 and 2031
  • Figure 65: Middle East & Africa Brain Cancer Diagnostics Market Attractiveness , by Brain Cancer Type 2023-2031
  • Figure 66: Middle East & Africa Brain Cancer Diagnostics Market Value Share Analysis, by End-user 2023 and 2031
  • Figure 67: Middle East & Africa Brain Cancer Diagnostics Market Attractiveness, by End-user 2023-2031